The Gynecologic Cancer Program provides complete and compassionate care for
women with gynecologic cancers including ovarian, uterine, cervical, vulvar, peritoneal, and fallopian tube cancers, as well as gestational trophoblastic disease.
Rodriguez - Rodriguez L, Hirshfield KM, Rojas V, DiPaola RS, Gibbon D, Hellmann M, Isani S, Leiser A, Riedlinger GM, Wagreich A, Ali SM, Elvin JA, Miller VA, Ganesan S. Use of comprehensive genomic profiling to direct point - of - care management of
patients with gynecologic cancers.
An oral cancer drug improves outcomes while minimizing side effects in women
with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.
«Based on our estimates, it's likely that more than 7,000 women
with gynecologic cancers per year experience distance - related barriers to accessing appropriate care from a specialist.
She beat the disease and is now
working with the Gynecologic Cancer Foundation to educate women about human papillomavirus (HPV)-- a group of viruses that cause the vast majority of cervical cancer cases — and the importance of regular Pap tests to screen for cervical cancer.
According to the Centers for Disease Control and Prevention, 71,500 women are
diagnosed with a gynecologic cancer each year in the United States, with 26,500 deaths from one of these diseases.
As part of an ongoing clinical trial at Rutgers Cancer Institute exploring rare and poor prognosis cancers, investigators sought to identify genomic alterations in 69
patients with gynecologic cancers that were not responding to standard care.
To learn more about current immunotherapy treatment options for
women with gynecologic cancers, and how close we are to making these treatments available to more patients, watch Dr. Odunsi's webinar from June 4, 2013.
Minimally invasive and robotic surgery is now used for treatment of a majority of women
with gynecologic cancer.